CN103609526B - The application of mitochondrial protein translation factor Guf1 in male sterile research - Google Patents
The application of mitochondrial protein translation factor Guf1 in male sterile research Download PDFInfo
- Publication number
- CN103609526B CN103609526B CN201310485227.5A CN201310485227A CN103609526B CN 103609526 B CN103609526 B CN 103609526B CN 201310485227 A CN201310485227 A CN 201310485227A CN 103609526 B CN103609526 B CN 103609526B
- Authority
- CN
- China
- Prior art keywords
- guf1
- mouse
- gene
- mitochondrial
- testis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000011160 research Methods 0.000 title abstract description 20
- 230000022886 mitochondrial translation Effects 0.000 title description 7
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 58
- 238000000034 method Methods 0.000 claims description 21
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- 230000014509 gene expression Effects 0.000 claims description 9
- 230000002159 abnormal effect Effects 0.000 claims description 7
- 241000124008 Mammalia Species 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 230000021595 spermatogenesis Effects 0.000 abstract description 6
- 238000003209 gene knockout Methods 0.000 abstract description 5
- 230000007246 mechanism Effects 0.000 abstract description 4
- 238000010172 mouse model Methods 0.000 abstract description 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 53
- 210000001550 testis Anatomy 0.000 description 42
- 102000004169 proteins and genes Human genes 0.000 description 33
- 235000018102 proteins Nutrition 0.000 description 32
- 210000000918 epididymis Anatomy 0.000 description 25
- 201000010063 epididymitis Diseases 0.000 description 25
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 239000000203 mixture Substances 0.000 description 17
- 210000003470 mitochondria Anatomy 0.000 description 16
- 210000002216 heart Anatomy 0.000 description 15
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 14
- 230000008859 change Effects 0.000 description 14
- 238000011813 knockout mouse model Methods 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- 239000003292 glue Substances 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 10
- 230000002438 mitochondrial effect Effects 0.000 description 10
- 239000002953 phosphate buffered saline Substances 0.000 description 10
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 9
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 9
- 229930006000 Sucrose Natural products 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 239000004567 concrete Substances 0.000 description 9
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 9
- 229960004793 sucrose Drugs 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- 108020005196 Mitochondrial DNA Proteins 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 238000000055 blue native polyacrylamide gel electrophoresis Methods 0.000 description 8
- 239000005720 sucrose Substances 0.000 description 8
- 230000014616 translation Effects 0.000 description 8
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 230000005540 biological transmission Effects 0.000 description 7
- 230000034994 death Effects 0.000 description 7
- 238000003119 immunoblot Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 229910001629 magnesium chloride Inorganic materials 0.000 description 7
- 230000019100 sperm motility Effects 0.000 description 7
- 108090000365 Cytochrome-c oxidases Proteins 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
- 239000006180 TBST buffer Substances 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 230000008811 mitochondrial respiratory chain Effects 0.000 description 6
- 238000013519 translation Methods 0.000 description 6
- 238000001262 western blot Methods 0.000 description 6
- 108010058682 Mitochondrial Proteins Proteins 0.000 description 5
- 102000006404 Mitochondrial Proteins Human genes 0.000 description 5
- 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 description 5
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 5
- 230000006907 apoptotic process Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 238000013016 damping Methods 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 210000001671 embryonic stem cell Anatomy 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000012188 paraffin wax Substances 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 230000008685 targeting Effects 0.000 description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 4
- 238000007400 DNA extraction Methods 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000007995 HEPES buffer Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 239000012160 loading buffer Substances 0.000 description 4
- 239000006166 lysate Substances 0.000 description 4
- 230000013011 mating Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000026731 phosphorylation Effects 0.000 description 4
- 238000006366 phosphorylation reaction Methods 0.000 description 4
- 238000012797 qualification Methods 0.000 description 4
- 108091092562 ribozyme Proteins 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000011740 C57BL/6 mouse Methods 0.000 description 3
- 101150018198 COX1 gene Proteins 0.000 description 3
- 102100025287 Cytochrome b Human genes 0.000 description 3
- 108010075028 Cytochromes b Proteins 0.000 description 3
- 101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 239000002532 enzyme inhibitor Substances 0.000 description 3
- 210000003527 eukaryotic cell Anatomy 0.000 description 3
- 230000008676 import Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000004898 mitochondrial function Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000010827 pathological analysis Methods 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 3
- 238000010814 radioimmunoprecipitation assay Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000035806 respiratory chain Effects 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102100030497 Cytochrome c Human genes 0.000 description 2
- 108010075031 Cytochromes c Proteins 0.000 description 2
- 101100275424 Danio rerio mt-co1 gene Proteins 0.000 description 2
- 101100275428 Dictyostelium discoideum cox1/2 gene Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108700024394 Exon Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 101001023513 Homo sapiens NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial Proteins 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000581650 Ivesia Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 102100035383 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial Human genes 0.000 description 2
- 101150062589 PTGS1 gene Proteins 0.000 description 2
- 101150000187 PTGS2 gene Proteins 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 101150115979 guf1 gene Proteins 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000004202 respiratory function Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000002277 temperature effect Effects 0.000 description 2
- MEIRRNXMZYDVDW-MQQKCMAXSA-N (2E,4E)-2,4-hexadien-1-ol Chemical compound C\C=C\C=C\CO MEIRRNXMZYDVDW-MQQKCMAXSA-N 0.000 description 1
- VONNHDXCCQVFQI-UHFFFAOYSA-N 1-methylphenazin-10-ium;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2N=C3C(C)=CC=CC3=[NH+]C2=C1 VONNHDXCCQVFQI-UHFFFAOYSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- BMUDPLZKKRQECS-UHFFFAOYSA-K 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid iron(3+) hydroxide Chemical compound [OH-].[Fe+3].[N-]1C2=C(C)C(CCC(O)=O)=C1C=C([N-]1)C(CCC(O)=O)=C(C)C1=CC(C(C)=C1C=C)=NC1=CC(C(C)=C1C=C)=NC1=C2 BMUDPLZKKRQECS-UHFFFAOYSA-K 0.000 description 1
- ZGZLYKUHYXFIIO-UHFFFAOYSA-N 5-nitro-2h-tetrazole Chemical compound [O-][N+](=O)C=1N=NNN=1 ZGZLYKUHYXFIIO-UHFFFAOYSA-N 0.000 description 1
- 102100021921 ATP synthase subunit a Human genes 0.000 description 1
- 102100027573 ATP synthase subunit alpha, mitochondrial Human genes 0.000 description 1
- QGZKDVFQNNGYKY-OUBTZVSYSA-N Ammonia-15N Chemical compound [15NH3] QGZKDVFQNNGYKY-OUBTZVSYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101150001086 COB gene Proteins 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108050008072 Cytochrome c oxidase subunit IV Proteins 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 101000678286 Danio rerio Eukaryotic translation initiation factor 4E-binding protein 3-like Proteins 0.000 description 1
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
- 101000800913 Dictyostelium discoideum Eukaryotic translation initiation factor 4E-1A-binding protein homolog Proteins 0.000 description 1
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 1
- 101000800906 Drosophila melanogaster Eukaryotic translation initiation factor 4E-binding protein Proteins 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 101000753741 Homo sapiens ATP synthase subunit a Proteins 0.000 description 1
- 101000936262 Homo sapiens ATP synthase subunit alpha, mitochondrial Proteins 0.000 description 1
- 101000936965 Homo sapiens ATP synthase-coupling factor 6, mitochondrial Proteins 0.000 description 1
- 101000633984 Homo sapiens Influenza virus NS1A-binding protein Proteins 0.000 description 1
- 101000601568 Homo sapiens NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 Proteins 0.000 description 1
- 101001128687 Homo sapiens NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial Proteins 0.000 description 1
- 101000979227 Homo sapiens NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial Proteins 0.000 description 1
- 101000604411 Homo sapiens NADH-ubiquinone oxidoreductase chain 1 Proteins 0.000 description 1
- 101000632623 Homo sapiens NADH-ubiquinone oxidoreductase chain 6 Proteins 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- 102100029241 Influenza virus NS1A-binding protein Human genes 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 101150053771 MT-CYB gene Proteins 0.000 description 1
- 108700036248 MT-RNR1 Proteins 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 241000713869 Moloney murine leukemia virus Species 0.000 description 1
- 241000714177 Murine leukemia virus Species 0.000 description 1
- 108010086428 NADH Dehydrogenase Proteins 0.000 description 1
- 102000006746 NADH Dehydrogenase Human genes 0.000 description 1
- 102100037524 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 Human genes 0.000 description 1
- 102100023212 NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial Human genes 0.000 description 1
- 102100028386 NADH-ubiquinone oxidoreductase chain 6 Human genes 0.000 description 1
- 241001045988 Neogene Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
- 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- IYPRWQPJYRBHIS-UHFFFAOYSA-N acetic acid;uranium Chemical compound [U].CC(O)=O IYPRWQPJYRBHIS-UHFFFAOYSA-N 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000002337 anti-port Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003883 azoospermia Diseases 0.000 description 1
- 230000035559 beat frequency Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- HOQPTLCRWVZIQZ-UHFFFAOYSA-H bis[[2-(5-hydroxy-4,7-dioxo-1,3,2$l^{2}-dioxaplumbepan-5-yl)acetyl]oxy]lead Chemical compound [Pb+2].[Pb+2].[Pb+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HOQPTLCRWVZIQZ-UHFFFAOYSA-H 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 108091006044 chimera Proteins 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 101150006264 ctb-1 gene Proteins 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 1
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000027721 electron transport chain Effects 0.000 description 1
- 108010063460 elongation factor T Proteins 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- -1 fluoroalkyl compound Chemical class 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000007849 functional defect Effects 0.000 description 1
- 150000008195 galaktosides Chemical class 0.000 description 1
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
- 229960002963 ganciclovir Drugs 0.000 description 1
- 238000010363 gene targeting Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-M glutaminate Chemical compound [O-]C(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-M 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 102000050479 human NDUFS3 Human genes 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007758 mating behavior Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- HCAONSFIGUBAPW-UHFFFAOYSA-N methyl hydrogen sulfate;phenazine Chemical compound COS(O)(=O)=O.C1=CC=CC2=NC3=CC=CC=C3N=C21 HCAONSFIGUBAPW-UHFFFAOYSA-N 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000005787 mitochondrial ATP synthesis coupled electron transport Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 101150088166 mt:Cyt-b gene Proteins 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 101150091879 neo gene Proteins 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 210000004336 spermatogonium Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention provides the purposes of model animals mouse in research male sterile mechanism knocking out Guf1 gene, more specifically, the invention provides the purposes of mouse model in research mankind arrenotoky, spermatogenesis and male sterile mechanism and treatment for Guf1 gene knockout, likely will become the male sterile a kind of diagnostic method of diagnosis.
Description
Technical field
The present invention relates to the application of mitochondrial protein translation factor Guf1 in arrenotoky research.Particularly, the invention provides the purposes of model animals mouse in research male sterile process knocking out Guf1 gene, more specifically, the invention provides the purposes of mouse model in research mankind arrenotoky, spermatogenesis and male sterile mechanism and treatment for Guf1 gene knockout.
Background technology
At present, the whole world about has 15% married couple to be subject to infertile puzzlement, and azoospermia accounts for 19% in male sterility, become the common disease that affects male fertility because of.Sperm motility institute energy requirement is mainly from the oxidative phosphorylation of mitochondrial respiratory chain.If oxidation phosphorylation function is abnormal, enzymic activity or expression amount change and the variation etc. of Mitochondrial DNA all may cause plastosome energy dyssynthesis, reduce motility of sperm.Nineteen fifty-five, Hoffman-Berling first proving ATP is the energy derive of sperm tail motion, so mitochondrial structure and function state is one of important indicator evaluating sperm quality.The dependency of structure of mitochondria and dysfunction and low sperm activity causes concern in recent years.
Plastosome is the main cell device that cell carries out aerobic oxidation; every vital movement of cell is nearly all provide energy by Mitochondria; and the motion of sperm needs a large amount of energy supplies; therefore the oxidation phosphorylation function of mitochondria of sperms respiratory chain has vital effect to maintenance sperm normal vital; if its dysfunction directly may affect generation and the transmission of energy, cause sperm motility obstacle.At present, both at home and abroad some high oxygen consumptions, histoorgan that energy requirement is large are mainly concentrated on to the research of mitochondrial respiratory function and respiratory chain energy metabolism, as liver organization, cerebral tissue, cardiac muscular tissue etc., these high oxygen consumptions organize mitochondrial obstacle that membrane potential can be caused to decline, ATP generates and greatly reduces, and affects the function of histoorgan.And maintain sperm proper motion and need a large amount of Power supplies, therefore the research of mitochondria of sperms respiratory function and respiratory chain energy metabolism is just had great importance.
LepA can be combined the antiport causing tRNA as prokaryotic cell prokaryocyte protein translation elongation factor with rrna, can increase the fidelity of protein translation in vitro.The eukaryotic cell homologous protein Guf1 albumen of lepA is the albumen being positioned mitochondrial matrix guarded very much, the yeast cell having research that Guf1 protein mutation is described under cryogenic mitochondrial protein synthesis speed slows down, temperature raises mitochondrial cytochrome c oxidase activity and reduces, thus shows that Guf1 albumen is the fidelity factor important in mitochondrial protein synthesis process.Therefore the functional study of Guf1 albumen in higher animal body is even more important.
Summary of the invention
Our research finds that Guf1 albumen generates significant for mouse sperm.Guf1 protein knockout causes mouse sperm generating process to occur obstacle, and sperm number significantly reduces, and Sperm Motility declines, and further research finds that this is relevant with the Mitochondria functional defect of testis.Guf1 albumen causes mitochondrial protein to translate acceleration but translation product fidelity difference causes its degraded to accelerate to be likely the handicapped major reason of Mitochondria.
Our Late Cambrian Guf1 albumen in model animals mouse has important regulating and controlling effect to arrenotoky mitochondrial function.Knocking out of Guf1 protein coding gene can make mouse dyszoospermia, has a strong impact on spermatogenesis and the maturation of mouse, provides important target spot for studying arrenotokous mechanism and treating.
More specifically, the invention provides the following:
1. obtain an inhuman male sterile mammiferous method, described method comprises cultivate that Guf1 gene is knocked described mammiferous male.
2. the method according to 1, wherein said Mammals is mouse, and the sequence of described Guf1 gene is as shown in SEQ ID NO:1.
3. cause the method that inhuman boar is sterile, described method comprises the Guf1 abnormal gene expression making described boar.
4. the method according to 3, wherein said Mammals is mouse, and the sequence of described Guf1 gene is as shown in SEQ ID NO:1.
5.Guf1 gene is as the purposes of the target spot causing inhuman boar sterile.
6. the purposes according to 5, wherein said Mammals is mouse, and the sequence of described Guf1 gene is as shown in SEQ ID NO:1.
7. for the reagent that detects mammiferous Guf1 abnormal gene expression for the preparation of the purposes detected in described mammiferous male sterile diagnostic reagent.
8. the test kit for diagnosing boar sterile, described test kit comprises the reagent for detecting described mammiferous Guf1 gene unconventionality.
Accompanying drawing explanation
The strategy of Fig. 1: Guf1 gene knockout and PCR, protein immunoblot detect;
Fig. 2: the Guf1 male sterile pathological analysis caused knocked out;
Fig. 3: Guf1 knocks out increase spermoblast apoptosis, affects spermatogenesis;
The testis of Fig. 4: Guf1 knock-out mice and the transmission electron microscope observing of mitochondria of sperms;
Fig. 5: Guf1 albumen is on the impact of mitochondrial respiratory chain cpd function;
Fig. 6: Guf1 knocks out the impact on mitochondrial respiratory chain protein compound subunit;
Fig. 7: Guf1 knock out cause kytoplasm translate reduce and mTOR signal path reduction;
Fig. 8: Guf1 protein knockout copies plastosome, the impact of transcribing and translating.
Fig. 9: the preservation of human spermatogoa and the extraction of genomic dna thereof.
Embodiment
The strategy of embodiment 1, Guf1 gene knockout and PCR, protein immunoblot detect.
In order to study the function of Guf1 albumen in higher organism and which impact sudden change can produce to body.We select this model animals of mouse, use gene targeting to be knocked out by Guf1 albumen, and use the method for PCR and protein immunoblot to evaluate the efficiency knocked out.Fig. 1 is that the strategy of Guf1 protein knockout and PCR and protein immunoblot detect and knock out efficiency.Figure 1A shows that Guf1's knocks out the Guf1 knock out mice genotype that tactful Figure 1B represents PCR qualification.Figure 1B represents western blot and detects Guf1 knock out efficiency in mouse tissue.Result shows that Guf1 protein content significantly reduces in testis, prove further this albumen in mouse disallowable fall.
Concrete grammar:
The acquisition of Guf1 knock out mice:
The structure of Guf1 targeting vector: obtain Guf1 gene from the 129BAC (bMQ-420K22) clone (purchased from Welcome TrustSanger Institute) containing mouse Guf1 gene (nucleotide sequence of Guf1 gene is as shown in SEQ.ID.NO.1), as shown in Figure 1A.Loxp site (its sequence is GAATTCCTGCAGCCCAATTCCGATC) is added in this gene second to the 8th exon both sides, between exon 8 and exon 9, add the screening that neomycin resistance gene (neo gene, sequence is as shown in SEQ ID NO.2) carries out next step simultaneously.The sequence of targeting vector is as shown in SEQ ID NO.3.
The embryonic stem cell stage: after targeting vector has built, middle body target practice plasmid (about needing to prepare 100ug) electricity proceeds in embryonic stem cell mouse 129 cell (purchased from Nanjing biological medicine research institute) of homology, make the Guf1 gene on targeting vector and embryonic stem cell genome generation homologous recombination, namely on targeting vector, Guf1 exons 1 and exon 8 exchange with the identical sequence on embryonic stem cell Guf1 genome, and then are knocked out to exon 8 by the exon 2 of Guf1.Restructuring Embryonic stem cell clones is obtained, go forward side by side performing PCR and southernblot qualification by G418 and gancyclovir positive-negative selection.
Blastaea injection stage: the ES cell correctly hit that increases clones, microinjection is in the blastaea of C57BL/6 mouse (Nanjing biological medicine research institute), and this blastaea is transplanted to female mouse C57BL/6 (the Nanjing biological medicine research institute) intrauterine of replace-conceive, male and 2 the female Chi-meric mice of output 8.7 Male chimeras mouse and C57BL6 mouse hybrid, bear 20 hybrid mice (Guf1
flox/+).Hybrid mice Guf1
flox/+male and female mate, and produce offspring, and PCR qualification obtains Guf1
flox/foxmouse, carries out mating with EIIa-cre mouse (Military Medical Science Institute), obtains Guf1 and knocks out type and chimeric mice.
Clip and digestion mouse tail: mated by Guf1 genetic heterozygosis mouse, newborn wild, heterozygosis is with when knocking out the birth of type mouse to about 18 days, and from breast, point cage, gets out the scissors of sterilizing, tweezers, EP pipe, cotton ball soaked in alcohol.Deduct one section of about 0.5cm from newborn mice afterbody tip, put into EP pipe.Preparation mouse tail Digestive system (20mM Tris-HCl, 5mM EDTA, 0.4M sodium-chlor, 1% SDS, 400 μ g/ml Proteinase Ks), get 400 μ l and join in EP pipe, 55 degree of digestion are spent the night.
Extract mouse genome: by centrifugal for mouse Digestive system 11000rpm 5 minutes, supernatant is poured in a new EP pipe, adds 200 μ l saturated sodium-chlorides, teetertotter 200 times, place 10 minutes on ice, centrifugal 10 minutes of 14000rpm.Be poured into by supernatant in a new EP pipe, add 800 μ l dehydrated alcohols, centrifugal 5 minutes of 14000rpm, abandons supernatant, and precipitation DNA room temperature adds 50 μ l distilled waters after drying.
PCR identifies: synthesis PCR primers designed (the raw work synthesis in Shanghai), and primer sequence is as follows:
Loxpt F2:5’TTTGTCCTAAATGCGTGGTG 3’
Loxpt R2:5’CCCGCTCCCTAATAAAGATG 3’
Frtt R2:5’CGATCCCTGTACTCAAGACC 3’
Reaction system is as follows:
2x Taq mix:10μl
Loxpt F2:0.5μl
Loxpt R2(Frtt R2):0.5μl
Genomic dna: 1.5 μ l
RT-PCR amplification condition: sex change-95 is spent, 5 minutes; Annealing-60 degree, 45 seconds; Extend-72 degree, 1 minute; Cycle index: 30 times; Finally extend condition-72 to spend, 10 minutes.PCR sample carries out agarose gel electrophoresis (gum concentration: 1%).
Protein immunoblot: mating is mated 6-8 wild-type in age in week that PCR qualification obtains and the Guf1 knock out mice neck that breaks and put to death, take out heart and testis tissue, PBS rinsing.Add RIPA lysate 1ml, put into tissue grinder's grinding, homogenate places 30 minutes on ice, centrifugal 30 minutes of 12000rpm, supernatant BCA kit measurement protein concentration.
Prepare 15% SDS-PAGE glue, will survey the sample of protein concentration, added the sample-loading buffer of certain volume, 95 degree of heating 15 minutes, get 50 μ g albumen and join in 15% SDS-PAGE glue, 100v constant voltage, runs 3 hours.
Transfer on pvdf membrane by the protein sample on glue, 5% skim-milk closes 1 hour, then adds the anti-Guf1 antibody (sigma) of 1:1000 dilution, overnight incubation.TBST washes film 5 times, each 5 minutes.Add the rabbit two anti-(JacksonImmunoResearch) of the horseradish peroxidase mark of 1:3000 dilution, hatch 1.5 hours.TBST (150mM NaCl, 20mM Tris-HCl, pH7.4, Tween-20 0.05%) adds the excess of imports quick ECL chemical illuminating reagent (green skies company) after washing film three times, puts into magazine and exposes.
The male sterile pathological analysis that embodiment 2, Guf1 gene knockout cause.
In order to the disappearance studying Guf1 further can cause those dysfunctions, we carry out pathological research to the reproduction of Guf1 knock out mice emphatically, comprise offspring's number, Sperm Motility, and the pathological section of testis and TEM (transmission electron microscope) analysis.Fig. 2 A represents the analysis of offspring's number, shows malely to knock out after type mouse and normal female mouse mate, and has mating behavior but does not produce offspring.Fig. 2 B adds up the sperm number of wild-type and Guf1 knock-out mice, shows that Guf1 knock-out mice sperm number significantly reduces.Fig. 2 C is that Testis Morphology is observed, and finds that the Testis Morphology of Guf1 knock-out mice diminishes.Fig. 2 D is confocal fluorescent microscopic examination sperm morphology, finds that knocking out type mitochondria of sperms sheath has disappearance, bending phenomenon, abnormalities.
Concrete grammar:
Arrenotoky capability analysis: get 6-8 week 20 wild-types in age respectively and Guf1 knocks out type mouse, the female mouse of CD1 in every mouse and two 6-7 age in week mates, every morning tests bolt, raise there being the mouse of cloudy bolt to take out separately, add up algebraically order thereafter, found that and 40 of wild-type mice mating female mouse, all see bolt, only have two not have offspring, all the other bear 4-12 only young mouse.And with knock out 40 female mouse of CD1 of type mouse mating, see bolt but there is no offspring.
Sperm number is added up: get 6-8 wild and knock out type mouse (n>3) for age in week, disconnected neck is put to death, and takes out epididymis, put into the plate that phosphate buffered saline buffer (PBS) is housed with scissors, pricked by epididymis broken with syringe, blood counting chamber counts.
Confocal fluorescent microscopic examination sperm morphology: get 6-8 wild and knock out type mouse (n>3) for age in week, disconnected neck is put to death, epididymis is taken out with scissors, epididymis is pricked broken by syringe, Hoechest and Mitotracker (invitrogen) PBS 1:10000 dilution, confocal fluorescent microscopic examination sperm.
Embodiment 3, Guf1 knock out increases spermoblast apoptosis, affects spermatogenesis.
In order to study the impact of Guf1 for mouse sperm generating process, we comprise testis to the reproductive organ that wild-type and Guf1 knock out male mouse and epididymis carries out section statining, and Sperm Motility analysis.Fig. 3 A, C are that the H & E knocking out type epididymis and testis dyes, and this result shows to knock out in type mouse epididymis and there is a large amount of prematurity spermoblasts.Fig. 3 B is the apoptosis phenomenon that TUNEL detects in testis and epididymis, shows produce obvious apoptosis phenomenon after Guf1 knocks out.Fig. 3 D, E are computer aided sperm analysis (computer assisted sperm analyzer, the CASA) analyses to Sperm Motility, and result shows that knock-out mice Sperm Motility obviously reduces.By the above pathological analysis knocked out Guf1, find that Guf1 knocks out and can cause spermatogenesis obstacle, cause male sterile.
Concrete grammar:
The H & E of epididymis and testis dyes:
Paraffin section: take off wild-type and Guf1 knock out mice testis and epididymis tissue, put into (the Polyfluoroalkoxy of fluoroalkyl compound excessively of 4%, PFA) fixing in, to prevent cell self-dissolving after death or the decomposition of bacterium, thus the morphological structure keeping cell original.
Dewater transparent: make dewatering agent with by lower concentration to the ethanol of high density, slough the moisture in tissue gradually.Then be put in transparent base dimethylbenzene transparent.
Waxdip embeds: will pour the paraffin melted in capsule into, and tissue is put in wherein, cooled and solidified.
Section and paster: be put in slicing machine by embedded wax stone, thinly slice, 5-8 μm, thin slice is put in the hot water of 42 degree and opens up sheet, is attached on slide glass, is put in thermostat container and dries.
Dewaxing dyeing: before dyeing, the paraffin section of oven dry is put in dimethylbenzene and sloughs paraffin, then via high density to low-concentration ethanol, finally join distilled water.Slice, thin piece is put in the phenodin aqueous solution several minutes that dyes, and running water adds distilled water for a moment after 1 hour, enter in 70% and 90% alcohol to dewater each 10 minutes.Add eosin stains liquid dyeing 2-3 minute.
Dewater transparent: after dyeing, section is through the ethanol dehydration of different concns, then makes section transparent through dimethylbenzene.
Sealing: upper natural gum is dripped in transparent good section, covered sealing.
TUNEL apoptosis detects:
Make the paraffin section of testis and epididymis, section dimethylbenzene embathes 2 times, each 5 minutes.Transparent good slice, thin piece is put in graded ethanol (100%, 95%, 90%, 80%, 70%) and respectively embathes 1 time, each 3 minutes.Slice, thin piece PBS washs 2 times.20 minutes are organized with the process of Proteinase K working fluid.PBS washs 2 times afterwards.Preparation TUNEL reaction mixture, the fluorescein-labeled dUTP liquid mixing of 50 μ l TdT+450 μ l.50 μ l TUNEL reaction mixtures are added, 37 degree of reactions 1 hour in dark wet box after slice, thin piece is dry.PBS rinsing 3 times.Take pictures.
Computer aided sperm analysis (CASA) evaluates the every kinematic parameter of sperm: get 6-8 wild-type in age in week and knock out each 4 of type mouse, its epididymis is taken out, sperm is placed in 37 degree of water-baths, counting cell puts pre-temperature on analyser temperature-constant plate, sperm sample post liquefaction is got mixing sample seminal fluid 1 and is dropped in the middle of sample pool, then analyzes.Section's computer-assisted semen analysis software (animal institute of the Chinese Academy of Sciences) in employing, analyzes semen parameters and motility of sperm and sperm averaged curve movement velocity (VCL), mean linear movement velocity (VSL), average path movement velocity (VAP), average beat frequency (BCF) etc.
Embodiment 4, the testis of Guf1 knock-out mice and the transmission electron microscope observing of mitochondria of sperms.
Research in the past shows, Guf1 is positioned mitochondrial albumen.In order to study the impact of Guf1 albumen on mitochondrial function, we study the structure of mitochondria of the reproductive organ of Guf1 knock-out mice and function.Fig. 4 is the impact that Guf1 knocks out on mouse testis and mitochondria of sperms form.Fig. 4 A, C represent spermatogonium and the spermatocyte transmission electron microscope of Guf1 protein knockout respectively, and result shows that Guf1 knock-out mice is grown spermatocyte Mitochondrial Shape and changed.Fig. 4 B, D represent the mitochondria of sperms sheath of Guf1 knock-out mice, and result display Guf1 disappearance can cause mitochondria of sperms form to occur obviously to change, and be embodied in mitochondria of sperms sheath plastosome and put irregular, interior ridge has defect.
Concrete grammar:
Testis and epididymis organize transmission electron microscope: testis and epididymis, from wild and knock out type mouse live body and take off, put into perosmic anhydride and fixed 1-2 hour.Fixing complete, dewater after 20 minutes with damping fluid rinsing.Dehydration gradient is followed successively by: 30% acetone, 50% acetone, 70% acetone, 80% acetone, 90% acetone, and every grade acts on 30 minutes.Pure acetone effect 3 times, each 30 minutes.Do ultrathin section(ing) after sample permeates, finally dye, first lead citrate dyes 10 minutes, goes the distilled water of carbonic acid gas to clean 3 times, then dyes 30 minutes with acetic acid uranium, and distilled water cleans 3 times.After ultrathin section(ing) drying, transmission electron microscope Tecnai Spirit (120KV) can be gone up and observe.
Embodiment 5, Guf1 albumen are on the impact of mitochondrial respiratory chain cpd function.
In order to study the impact of Guf1 for mitochondrial function further, we study Mitochondria system, in contrast with healthy tissues heart simultaneously.Fig. 3 A represents wild-type and knocks out the ATP level of type testis and epididymis, and result is presented at testis and epididymis ATP level when Guf1 knocks out and declines.Fig. 3 B represents the oxidasic activity of mitochondrial cytochrome c, and result shows that the activity of cytochrome c oxidase in the testis that Guf1 knocks out and epididymis reduces.Fig. 3 C represents each mixture of Blue native PAGE analytical line mitochondrial respiratory chain, and result shows that the amount of cytochrome c oxidase obviously reduces knocking out in type testis and epididymis.Fig. 3 D represents the BNG dyeing of cytochrome c oxidase, and result shows that the activity of cytochrome c oxidase obviously reduces.Fig. 3 E represents line grain composite I, the active coloring of Complex II and mixture V, and result shows composite I, the activity of V, II does not have considerable change.
Concrete grammar:
ATP level determination: get 6-8 wild-type in age in week and the testis, the epididymis that knock out type mouse, PBS washes three times.Testis removes tunica albuginea, and sterilizing blade is by testis, and epididymis shreds, the trysinization of 0.25%, each 5 minutes, totally 15 minutes.Obtain unicellular, after lysis, centrifugal 10 minutes of 13000rpm, supernatant BCA kit measurement protein concentration.Get 5 μ l samples and add 50 μ l ATP detection buffer, chemoluminescence microplate reader (Perkin Elmer, USA) detector detects.
Blue Native PAGE: according to plastosome separating kit (Abcam) separating mouse heart and testis plastosome, BCA kit measurement protein concentration.Get 400 μ g plastosome 12000rpm centrifugal 5 minutes, it is resuspended to add 40 μ l buffer A (50mM sodium-chlor, 50mM imidazoles/hydrochloric acid, 1mMEDTA, pH 7.0).Often pipe adds 12 μ l Digitonin, and mixing acts on 10 minutes on ice.100000g, 4 degree centrifugal 30 minutes, gets supernatant, adds 5 μ l glycerine and 6 μ l Xylene Brilliant Cyanine Gs.Get 20 μ l samples and carry out Blue-native PAGE separate mitochondria mixture, method sees reference document (Ilka Wittig etc., nature 2006).
Composite I is active: Blue-native PAGE separation gel is incubated in 50mM Tris-Hcl, (containing 0.5mM NBT (Nitroblue tetrazolium chloride in pH 7.4 damping fluid, chlorination nitro tetrazole), 5mM NADH (Nicotinamide adenine dinucleotide, Reduced nicotinamide-adenine dinucleotide)), room temperature effect 1 hour.
Complex II is active: Blue-native PAGE separation gel is incubated in 50mM Tris-Hcl, (0.2mM PMS (Methylphenaziniummethylsulfate in pH 7.4 damping fluid, phenazinium methyl sulfate), 84mM succsinic acid, 50mM NBT), room temperature effect 1 hour.
Complex IV is active: Blue-native PAGE separation gel is incubated in 50mM Tris-Hcl, in pH 7.4 damping fluid (containing 0.1% diaminobenzidine, 24 unit/ml catalases, 0.1% cytochrome c), and 37 degree of effect 3-6 hour.
Mixture V is active: by the clear water rinsing 10 minutes of Blue-native PAGE separation gel, and the glycine buffer (pH 8.6) putting into 0.1M acts on 1 hour.Again separation gel is put into the damping fluid containing following ingredients: 35mM Tris alkali, 270mM glycine, 14mM magnesium sulfate, 5mMATP, 0.2% Silver Nitrate, 37 degree of effect 3-6 hour.
Embodiment 6, Guf1 knock out the impact on mitochondrial respiratory chain protein compound subunit.
More than research shows that Guf1 knocks out the active obviously decline of the electron transport chain cytochrome c oxidase that can cause mouse testis and epididymis, so we study the amount of each complex subunit of mitochondrial electron transport chain, in contrast with healthy tissues heart simultaneously.Figure A represents the western blot result of each sub-albumen of composite I-V in heart and testis and epididymis, result display to knock out in the testis of type mouse and epididymis Cox IV (nuclear gene encoding) in complex IV, and the amount of Cox1, Cox2 (chondriogen group coding) significantly reduces.In composite I, ND2 amount reduces, and NDUFA9 amount is without any change.In Complex II I, the amount of cytochrome b (CYTB) reduces knocking out in type testis, and the Core2 amount of core coding is constant.In Complex II, the amount of 70kd Fp does not change.In mixture V, ATP5A amount does not also change.Figure B is that the result of Blue native western blot shows that the amount of mitochondrial complex IV reduces further.Figure C is that Blue-native 2D result illustrates that the amount of each sub-albumen of complex IV reduces more remarkable compared with each sub-protein content of other mixture.
Concrete grammar:
Protein immunoblot (western blot): get the 6-8 week wild-type in age and Guf1 and knock out the type mouse neck that breaks and put to death, take out mouse heart, testis and epididymis tissue, PBS rinsing.Add RIPA lysate 1ml, add proteinase inhibitor cocktail (Roche) simultaneously, put into tissue grinder and grind, homogenate places 30 minutes on ice, centrifugal 30 minutes of 12000rpm, supernatant BCA kit measurement protein concentration.
Prepare 15% SDS-PAGE glue, will survey the sample of protein concentration, add the albumen sample-loading buffer of certain volume, 95 degree of heating 15 minutes, get a certain amount of albumen and join in 15%SDS-PAGE glue, 100v constant voltage, electrophoresis 3 hours.
Transfer on pvdf membrane by the protein sample on glue, 5% skim-milk closes 1 hour, and then different primary antibodie (Abcam) is diluted to specifications, overnight incubation.TBST (150mM NaCl, 20mM Tris-HCl, pH7.4, Tween-20 0.05%) washes film 5 times, each 5 minutes.Two anti-1:3000 dilutions, hatch 1.5 hours.TBST adds the excess of imports quick ECL chemical illuminating reagent (green skies company) after washing film three times, puts into magazine and exposes.
Blue-native 2D: first carry out Blue native PAGE electrophoresis according to above experimental technique, is then placed in stationary liquid and fixes 1 hour, coomassie brilliant blue staining more than 2 hours by glue.Glue is cut, is put in 1% mercaptoethanol (trace tetrabromophenol sulfonphthalein) and places 1 hour.Preparation 10%Tricine-SDS-PAGE, is placed in the spacer gel of Tricine-SDS-PAGE, constant current 20mA, coomassie brilliant blue staining after electrophoresis by glue, decolouring.
Embodiment 7, Guf1 knock out and cause kytoplasm to translate reduction and the reduction of mTOR signal path.
In order to study the function of Guf1 gene in eukaryotic cell, we study signal path change that Guf1 causes and kytoplasm translation skill discloses Guf1 meaning in vivo with this.Fig. 4 A is the phosphorylation chip results of testis, and result display Guf1 is main relevant to cancer, and mTOR signal path correlative protein expression reduces simultaneously.Fig. 4 B is the expression that western blot verifies mTOR signal path associated protein, and result shows that the Thr37/46 phosphorylation level of the substrate 4E-BP in mTOR downstream declines, consistent with chip results.Fig. 4 C is that cytoribosome display technique observes kytoplasm translation skill, found that knocking out the translation of type mouse kytoplasm reduces.
Concrete grammar:
Protein immunoblot (western blot): get 6-8 wild-type in age in week and Guf1 and knock out the type mouse neck that breaks and put to death, take out mouse heart and testis tissue, PBS rinsing.Add RIPA lysate 1ml, add proteinase inhibitor cocktail (Roche) and inhibitors of phosphatases (Roche), put into tissue grinder's grinding, homogenate places 30 minutes on ice, centrifugal 30 minutes of 12000rpm, supernatant BCA kit measurement protein concentration.
Preparation 15%SDS-PAGE glue, will survey the sample of protein concentration, has added the albumen sample-loading buffer of certain volume, and 95 degree of heating 15 minutes, get a certain amount of albumen and join in 15%SDS-PAGE glue, 100v constant voltage, electrophoresis 3 hours.
Transfer on pvdf membrane by the protein sample on glue, 5% skim-milk closes 1 hour, and then different primary antibodie (Cell signal technology) is diluted, overnight incubation to specifications.After TBST (150mM NaCl, 20mM Tris-HCl, pH7.4, Tween-20 0.05%) washes film 5 times, two anti-(horseradish peroxidase-labeled) 1:3000 dilute, and hatch 1.5 hours.TBST adds the excess of imports quick ECL chemical illuminating reagent (green skies company) after washing film 5 times, puts into magazine and exposes.
Cytoribosome display technique:
Preparation TMK lysis buffer:
The 1M Tris-Cl of 10mM Tris-Cl, pH 7.4:1ml
The 1M magnesium chloride of 10mM magnesium chloride: 0.5ml
The 1M Repone K of 100mM Repone K: 10ml
1%(v/v)Triton X-100:1ml
0.5% (w/v) Sodium desoxycholate: 0.5g
1U/ml RNA enzyme inhibitors: 2.5 μ l 40U/ μ l
The 1M DTT of 2mM DTT:200 μ l
Cycloheximide: 0.1mg/ml
Add DEPC-H
2o to 100ml.
Preparation 10%-50% sucrose: prepare with DEPC water at 4 degree.
The preparation (200ml) of 10% (w/v) sucrose solution:
Sucrose: 20g
The 1M Repone K of 100mM Repone K: 20ml
The magnesium chloride of 5mM magnesium chloride: 1ml
The 1M DTT of 2mM DTT:400 μ l
The 1M HEPES of 20mM HEPES, pH 7.4:4ml
The preparation (200ml) of 50% (w/v) sucrose solution:
Sucrose: 100g
The 1M Repone K of 100mM Repone K: 20ml
5mM magnesium chloride: 1ml of magnesium chloride
The 1M DTT of 2mM DTT:400 μ l
The 1M HEPES of 20mM HEPES, pH 7.4:4ml
With adding 2 μ l (40U/ μ l) RNA enzyme inhibitors and 50 μ l cycloheximides (100 μ g/ μ l) before in 50ml sucrose.Be put in gradient mix device preparation gradient.
Wild-type and Guf1 knock out the type mouse neck that breaks and put to death, and take out heart and testis immediately and are put in quick-frozen in liquid nitrogen, without the mortar grinder powdered of RNA enzyme, be poured in EP pipe, add TMK lysate, cracking on ice 5 minutes.Centrifugal 20 minutes of 13000g.Supernatant is laid in the saccharose gradient of 10%-50%.Centrifugal 4 hours of 26000rpm.Detection of nucleic acids instrument A260 detects.
Embodiment 8, Guf1 protein knockout copy plastosome, the impact of transcribing and translating.
Research in yeast shows, Guf1 is important mitochondrial protein translation factor.In order to study Guf1 impact on mitochondrial protein synthesis in eukaryotic cell further.We have done following research, and figure A measures the copy number that wild-type and Guf1 knock out the heart of type mouse, testis and epididymis Mitochondria DNA, and result shows that the copy number of Mitochondrial DNA increases to some extent.Figure C, E is the mRNA level in-site representing each complex proteins of plastosome, wherein C is the result of testis, E figure is heart result, result shows that the mRNA level in-site of each complex proteins of plastosome is in wild-type with knock out in type heart and testis and do not have considerable change, and Guf1 knocks out transcribing of not effect string mitochondrial DNA.Figure B is the amount change of mitochondrial ribosome large subunit L11 and small subunit ribosome S18, and the amount that result display knocks out L11 and S18 in type testis has increased slightly.Figure D is mitochondrial protein In Vitro Translation, and result shows in the testis knocked out at Guf1, and the in vitro translated amount of mitochondrial protein increases.
Concrete grammar:
The mensuration of mitochondria DNA copy number:
Extraction wild-type and Guf1 knock out the heart of type mouse and the DNA of testis, the primer of the cox1 gene primer that synthetic thread mitochondrial DNA (mtDNA) is encoded and the ndufv1 gene that nucleus DNA (nDNA) is encoded.With the genomic dna of heart and testis for template, qPCR increases cox1 and ndufv gene.The ratio of cox1 and ndufv represents mtDNA/nDNA.
Plastosome each complex proteins qPCR:Trizol reagent extraction wild-type and Guf1 knock out the total serum IgE of type mouse heart and testis, with 2 μ g total serum IgE for template, with moloney murine leukemia virus reversed transcriptive enzyme (Molony murine leukemia virus reverse transcriptase, MoMuLVRT) be template, with poly thymus pyrimidine (oligo (dT)) for primer synthesis cDNA. reference literature synthesis 16S rRNA, 12S rRNA, ND1, ND6, NDUFS3, NDUFS7, NDUFB6, NDUFA9 (nadh dehydrogenase subunit), Cox1, Cox2 (cytochrome oxidase subunit), CytB (cytochrome reductase subunit, cytochrome b), ATP6 (ATP synthetic enzyme subunit), EF-Tu (EF-T U) primer.RT-PCR reaction is carried out at ABIStepOne plus quantitative PCR apparatus with SYBR Green Master Mix (Takara, Japan) reagent.
Mitochondrial protein In Vitro Translation: extract with plastosome separating kit (Abcam) heart and the testis plastosome that wild-type and Guf1 knock out type mouse, BCA kit measurement mitochondrial protein concentration.100 μ g plastosome 12000g are centrifugal, precipitation reaction buffer 37 degree of reactions 1 hour.Reaction buffer composition is as follows: 25mM sucrose, 75mM sorbyl alcohol, 1mM magnesium chloride, 0.05mMEDTA, 10mM Tris-HCl, 10mM dipotassium hydrogen phosphate, 10mM glutaminate, 2.5mM oxysuccinic acid, 1mM ADP, 1mg/ml defatted bovine serum albumin, 100 μ g/ml sphingosyl galactosides, 100 μ g/ml cycloheximides, 0.2mM aminoacid mixture, the RNA enzyme inhibitors of 1 unit.
After having reacted, centrifugal 5 minutes of sample 12000g, with cold buffer liquid (320mM sucrose; 1mM EDTA; 10mM Tris-HCl, pH7.4) wash 3 times, precipitation adds 1x albumen sample-loading buffer 25 μ l, and 95 degree of heating 10 minutes, carry out 15%-20% SDS-PAGE electrophoresis.Make dry glue, pressure phosphorus screen.
The preservation of embodiment 9, human spermatogoa and the extraction of genomic dna thereof
The sperm (Tianjin hospital general) getting the sterile patient of 400 microlitre extracts genome, then checks order, Fig. 9 A represent extraction be numbered 1,2,3 patient's genome, result display extracts successfully.Checked order by above-mentioned DNA, Fig. 9 B represents sequencing result, and the 5 ' untranslated end that result is presented at the people guf1 gene of reproduction abnormality has the disappearance of two bases (TC).This experimental program that we adopt can successfully obtain sperm exonic DNA sequence, the site suddenlyd change by compare of analysis, therefore can become the basis that makes test kit.
Concrete grammar:
Sampling: room temperature water solubilisate (or 37 DEG C of water-bath liquefaction)
Frozen:
The sperm of liquefaction and frozen storing liquid are mixed by 1:1 and dropwise slowly adds, add while mix; 4 DEG C freezing 30 minutes, and liquid nitrogen 15 minutes is frozen.
Sperm DNA extracts:
1. get 200 μ l sperm+200 μ l Buffer X2 in 1.5ml centrifuge tube, 55 DEG C of water-baths at least 1 hour (1.5 hours), put upside down mixing every 10 minutes;
2. add Buffer AL (in QIAGEN DNA extraction kit composition) (may produce precipitation, 70 DEG C can the dissolve) vortex oscillation 15 seconds of 400 μ l, hatch 10 minutes for 70 DEG C, simply centrifugal, by the water droplet on lid from getting off;
3. add the ethanol (95%-100%) of 400 μ l, vortex oscillation mixes 15 seconds, simply from the water droplet (may produce precipitation, precipitate result without impact) on dry lid;
4. the 3rd step mixture is added in reaction column, centrifugal 1 minute of 8000rpm, change post (if from clean, recentrifuge) in a new 2ml collection tube;
5. add 500 μ l AW1 (in QIAGEN DNA extraction kit composition), centrifugal 1 minute of 8000rpm, change post in a new collection tube;
6. add 500 μ l AW2 (in QIAGEN DNA extraction kit composition), centrifugal 3 minutes of 14000rpm;
7. renew collection tube, centrifugal 1 minute of 14000rpm void column;
8. change a new 1.5ml centrifuge tube, add 100 μ l Buffer AE (in QIAGEN DNA extraction kit composition) or distilled water, room temperature places 1 minute, 8000rpm, centrifugal 1 minute (AE should add several times herein, guarantees that on pillar, the wash-out of DNA is abundant).
Table 1: the primer table of people guf1 gene extron order-checking
Primer label | Primer sequence | Order-checking exon |
1F | ACTGACAGTACACACACCACAG | 1st exon |
1R | AAGTTAGTGACTTGCCCAAGG | 1st exon |
2F | CTGATTGGCCCTAAAAATTG | 2 to the 4 exon |
2R | ACTAGTCAATTCCAGAGAATGC | 2 to the 4 exon |
3F | TGACCCCAAAGACATAAGTTG | 5th exon |
3R | GTGAGTTTCAGTTGCACTTCTG | 5th exon |
4F | TATTGTAGAGGGGTCAGTTAGG | 6th exon |
4R | AGTGATAAAACCTTTGAGCCTC | 6th exon |
5F | TACCCAGATTTCGAACTATTCC | 7 to the 8 exon |
5R | TCAACTGACGTTTCTATTGTCC | 7 to the 8 exon |
6F | TAAGACCTGGTGTGTTCATTTG | 9th exon |
6R | AACACATCCTAAATGATCTCCC | 9th exon |
7F | TTGGAGTGCAAATCTAGTTG | 10th and 11 exons |
7R_1 | AATCCGCAACGTGAAACAG | 10th exon |
7R_2 | GTTCTTCATCATTAGCCATAGG | 11st exon |
8F | CATGTAAGTGGCAATCTGTTC | 12nd exon |
8R | CTTTCCTTTGGGCTAACATATC | 12nd exon |
9F | TTTGGTAGCAAGCCTAATGC | 13rd exon |
9R | TGTTCCAAGTCATTCTAACC | 13rd exon |
10F | GATGGAAACATATCTCTTTGGG | 14th exon |
10R | GGTGAAGGGAAACATTTCTATG | 14th exon |
11F | TCCATTTGAACCTCCTTAAGAG | 15th exon |
11R | AAACTGGAGAGCACCATCATAC | 15th exon |
12F | CAAGCCTTGACCATTTTTTC | 16th exon |
12R | CATGGTCAAGCTGAAATTTACC | 16th exon |
13F | CTCCATCCAGATTAAATCCTG | 17th exon |
13R | CATGGCTTCAAAATCTAAGCTC | 17th exon |
Reference:
1.Acin-Perez,R.,Fernandez-Silva,P.,Peleato,M.L.,Perez-Martos,A.,and Enriquez,J.A.(2008).Respiratory active mitochondrial supercomplexes.Mol Cell 32,529-539.
2.Ashley,T.,Gaeth,A.P.,Creemers,L.B.,Hack,A.M.,and de Rooij,D.G.(2004).Correlation of meiotic events in testis sections and microspreads of mouse spermatocytesrelative to the mid-pachytene checkpoint.Chromosoma 113,126-136.
3.Azia,A.,Unger,R.,and Horovitz,A.(2012).What distinguishes GroEL substratesfrom other Escherichia coli proteins?The FEBS journal 279,543-550.
4.Barrientos,A.,Barros,M.H.,Valnot,I.,Rotig,A.,Rustin,P.,and Tzagoloff,A.(2002).Cytochrome oxidase in health and disease.Gene 286,53-63.
5.Bauerschmitt,H.,Funes,S.,and Herrmann,J.M.(2008).The membrane-boundGTPase Guf1 promotes mitochondrial protein synthesis under suboptimal conditions.TheJournal of biological chemistry 283,17139-17146.
6.Bruno,C.,Martinuzzi,A.,Tang,Y.,Andreu,A.L.,Pallotti,F.,Bonilla,E.,Shanske,S.,Fu,J.,Sue,C.M.,Angelini,C.,et al.(1999).A stop-codon mutationin the human mtDNA cytochrome c oxidase I gene disrupts the functional structure ofcomplex IV.American journal of human genetics 65,611-620.
7.Caldas,T.,Laalami,S.,and Richarme,G.(2000).Chaperone properties of bacterialelongation factor EF-G and initiation factor IF2.The Journal of biological chemistry 275,855-860.
8.Collins,T.J.,Berridge,M.J.,Lipp,P.,and Bootman,M.D.(2002).Mitochondriaare morphologically and functionally heterogeneous within cells.The EMBO journal 21,1616-1627.
9.De Martino,C.,Floridi,A.,Marcante,M.L.,Malorni,W.,Scorza Barcellona,P.,Bellocci,M.,and Silvestrini,B.(1979).Morphological,histochemical and biochemicalstudies on germ cell mitochondria of normal rats.Cell and tissue research 196,1-22.
10.Enders,G.C.,and May,J.J.,2nd(1994).Developmentally regulated expression ofa mouse germ cell nuclear antigen examined from embryonic day 11 to adult in male andfemale mice.Developmental biology 163,331-340.
11.Folgero,T.,Bertheussen,K.,Lindal,S.,Torbergsen,T.,and Oian,P.(1993).Mitochondrial disease and reduced sperm motility.Human reproduction 8,1863-1868.
12.Fontanesi,F.,Soto,I.C.,Horn,D.,and Barrientos,A.(2006).Assembly ofmitochondrial cytochrome c-oxidase,a complicated and highly regulated cellular process.American journal of physiology Cell physiology 291,C1129-1147.
13.Iadevaia,V.,Huo,Y.,Zhang,Z.,Foster,L.J.,and Proud,C.G.(2012).Rolesof the mammalian target of rapamycin,mTOR,in controlling ribosome biogenesis andprotein synthesis.Biochemical Society transactions 40,168-172.
14.Kao,S.,Chao,H.T.,and Wei,Y.H.(1995).Mitochondrial deoxyribonucleic acid4977-bp deletion is associated with diminished fertility and motility of human sperm.Biology of reproduction 52,729-736.
15.Koppen,M.,and Langer,T.(2007).Protein degradation within mitochondria:versatile activities of AAA proteases and other peptidases.Critical reviews in biochemistryand molecular biology 42,221-242.
16.Lee,I.,and Suzuki,C.K.(2008).Functional mechanics of the ATP-dependent Lonprotease-lessons from endogenous protein and synthetic peptide substrates.Biochimica etbiophysica acta 1784,727-735.
17.Li,Y.C.,Hu,X.Q.,Zhang,K.Y.,Guo,J.,Hu,Z.Y.,Tao,S.X.,Xiao,L.J.,Wang,Q.Z.,Han,C.S.,and Liu,Y.X.(2006).Afaf,a novel vesicle membrane protein,is related to acrosome formation in murine testis.FEBS Lett 580,4266-4273.
18.Luce,K.,Weil,A.C.,and Osiewacz,H.D.(2010).Mitochondrial protein qualitycontrol systems in aging and disease.Advances in experimental medicine and biology 694,108-125.
19.Meinhardt,A.,McFarlane,J.R.,Seitz,J.,and de Kretser,D.M.(2000).Activinmaintains the condensed type of mitochondria in germ cells.Molecular and cellularendocrinology 168,111-117.
20.Metodiev,M.D.,Lesko,N.,Park,C.B.,Camara,Y.,Shi,Y.,Wibom,R.,Hultenby,K.,Gustafsson,C.M.,and Larsson,N.G.(2009).Methylation of 12S rRNA isnecessary for in vivo stability of the small subunit of the mammalian mitochondrialribosome.Cell metabolism 9,386-397.
21.Mundy,A.J.,Ryder,T.A.,and Edmonds,D.K.(1995).Asthenozoospermia andthe human sperm mid-piece.Human reproduction 10,116-119.
22.Nakada,K.,Sato,A.,Yoshida,K.,Morita,T.,Tanaka,H.,Inoue,S.,Yonekawa,H.,and Hayashi,J.(2006).Mitochondria-related male infertility.Proceedingsof the National Academy of Sciences of the United States of America 103,15148-15153.
23.Pan,Y.,and Shadel,G.S.(2009).Extension of chronological life span by reducedTOR signaling requires down-regulation of Sch9p and involves increased mitochondrialOXPHOS complex density.Aging 1,131-145.
24.Piomboni,P.,Focarelli,R.,Stendardi,A.,Ferramosca,A.,and Zara,V.(2012).The role of mitochondria in energy production for human sperm motility.Int J Androl 35,109-124.
25.Qin,Y.,Polacek,N.,Vesper,O.,Staub,E.,Einfeldt,E.,Wilson,D.N.,and Nierhaus,K.H.(2006).The highly conserved LepA is a ribosomal elongation factor thatback-translocates the ribosome.Cell 127,721-733.
26.Rajender,S.,Rahul,P.,and Mahdi,A.A.(2010).Mitochondria,spermatogenesisand male infertility.Mitochondrion 10,419-428.
27.Ramalho-Santos,J.,Varum,S.,Amaral,S.,Mota,P.C.,Sousa,A.P.,and Amaral,A.(2009).Mitochondrial functionality in reproduction:from gonads and gametes toembryos and embryonic stem cells.Hum Reprod Update 15,553-572.
28.Reyes,J.G.,Farias,J.G.,Henriquez-Olavarrieta,S.,Madrid,E.,Parraga,M.,Zepeda,A.B.,and Moreno,R.D.(2012).The hypoxic testicle:physiology andpathophysiology.Oxidative medicine and cellular longevity 2012,929285.
29.Ruiz-Pesini,E.,Diez,C.,Lapena,A.C.,Perez-Martos,A.,Montoya,J.,Alvarez,E.,Arenas,J.,and Lopez-Perez,M.J.(1998).Correlation of sperm motility withmitochondrial enzymatic activities.Clinical chemistry 44,1616-1620.
30.Savel'ev,A.S.,Novikova,L.A.,Kovaleva,I.E.,Luzikov,V.N.,Neupert,W.,and Langer,T.(1998).ATP-dependent proteolysis in mitochondria.m-AAA proteaseand PIM1 protease exert overlapping substrate specificities and cooperate with the mtHsp70system.The Journal of biological chemistry 273,20596-20602.
31.Schieke,S.M.,Phillips,D.,McCoy,J.P.,Jr.,Aponte,A.M.,Shen,R.F.,Balaban,R.S.,and Finkel,T.(2006).The mammalian target of rapamycin(mTOR)pathwayregulates mitochondrial oxygen consumption and oxidative capacity.The Journal ofbiological chemistry 281,27643-27652.
32.Shoji,S.,Janssen,B.D.,Hayes,C.S.,and Fredrick,K.(2010).Translation factorLepA contributes to tellurite resistance in Escherichia coli but plays no apparent role in thefidelity of protein synthesis.Biochimie 92,157-163.
33.Smits,P.,Smeitink,J.,and van den Heuvel,L.(2010).Mitochondrial translationand beyond:processes implicated in combined oxidative phosphorylation deficiencies.Journal of biomedicine & biotechnology 2010,737385.
34.Spiropoulos,J.,Turnbull,D.M.,and Chinnery,P.F.(2002).Can mitochondrial DNAmutations cause sperm dysfunction?Molecular human reproduction 8,719-721.
35.St John,J.C.,Facucho-Oliveira,J.,Jiang,Y.,Kelly,R.,and Salah,R.(2010).Mitochondrial DNA transmission,replication and inheritance:a journey from the gametethrough the embryo and into offspring and embryonic stem cells.Hum Reprod Update 16,488-509.
36.Stiburek,L.,and Zeman,J.(2010).Assembly factors and ATP-dependent proteasesin cytochrome c oxidase biogenesis.Biochimica et biophysica acta 1797,1149-1158.
37.Suzuki,H.,Ueda,T.,Taguchi,H.,and Takeuchi,N.(2007).Chaperone propertiesof mammalian mitochondrial translation elongation factor Tu.The Journal of biologicalchemistry 282,4076-4084.
38.Tatsuta,T.(2009).Protein quality control in mitochondria.J Biochem 146,455-461.
39.Thorrez,L.,Van Deun,K.,Tranchevent,L.C.,Van Lommel,L.,Engelen,K.,Marchal,K.,Moreau,Y.,Van Mechelen,I.,and Schuit,F.(2008).Using ribosomalprotein genes as reference:a tale of caution.PloS one 3,e1854.
40.Tiranti,V.,Corona,P.,Greco,M.,Taanman,J.W.,Carrara,F.,Lamantea,E.,Nijtmans,L.,Uziel,G.,and Zeviani,M.(2000).A novel frameshift mutation of themtDNA COIII gene leads to impaired assembly of cytochrome c oxidase in a patientaffected by Leigh-like syndrome.Human molecular genetics 9,2733-2742.
41.Tsukihara,T.,Aoyama,H.,Yamashita,E.,Tomizaki,T.,Yamaguchi,H.,Shinzawa-Itoh,K.,Nakashima,R.,Yaono,R.,and Yoshikawa,S.(1996).The wholestructure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A.Science 272,1136-1144.
42.Wallace,D.C.(1999).Mitochondrial diseases in man and mouse.Science 283,1482-1488.
43.Wang,X.,and Proud,C.G.(2006).The mTOR pathway in the control of proteinsynthesis.Physiology(Bethesda)21,362-369.
44.Wilson,K.S.,and Prochaska,L.J.(1990).Phospholipid vesicles containing bovineheart mitochondrial cytochrome c oxidase and subunit III-deficient enzyme:analysis ofrespiratory control and proton translocating activities.Archives of biochemistry andbiophysics 282,413-420.
Claims (8)
1. obtain an inhuman male sterile mammiferous method, described method comprises cultivate that Guf1 gene is knocked described mammiferous male.
2. method according to claim 1, wherein said Mammals is mouse, and the sequence of described Guf1 gene is as shown in SEQ ID NO:1.
3. cause the method that inhuman boar is sterile, described method comprises the Guf1 abnormal gene expression making described boar.
4. method according to claim 3, wherein said Mammals is mouse, and the sequence of described Guf1 gene is as shown in SEQ ID NO:1.
5.Guf1 gene is as the purposes of the target spot causing inhuman boar sterile.
6. purposes according to claim 5, wherein said Mammals is mouse, and the sequence of described Guf1 gene is as shown in SEQ ID NO:1.
7. for the reagent that detects mammiferous Guf1 abnormal gene expression for the preparation of the purposes detected in described mammiferous male sterile diagnostic reagent caused by Guf1 abnormal gene expression.
8., for diagnosing the sterile test kit of boar caused by Guf1 abnormal gene expression, described test kit comprises the reagent for detecting described mammiferous Guf1 gene unconventionality.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310485227.5A CN103609526B (en) | 2013-10-16 | 2013-10-16 | The application of mitochondrial protein translation factor Guf1 in male sterile research |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310485227.5A CN103609526B (en) | 2013-10-16 | 2013-10-16 | The application of mitochondrial protein translation factor Guf1 in male sterile research |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103609526A CN103609526A (en) | 2014-03-05 |
CN103609526B true CN103609526B (en) | 2015-10-07 |
Family
ID=50160264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310485227.5A Active CN103609526B (en) | 2013-10-16 | 2013-10-16 | The application of mitochondrial protein translation factor Guf1 in male sterile research |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103609526B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110938652A (en) * | 2019-11-07 | 2020-03-31 | 浙江大学医学院附属第一医院 | Targeting vector, method for constructing F4/80-DTR transgenic mouse with diphtheria toxin regulation and elimination of macrophage and application |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1646562A (en) * | 2002-01-30 | 2005-07-27 | 爱丁堡大学 | Pluripotency determining factors and uses thereof |
CN101396564A (en) * | 2007-09-24 | 2009-04-01 | 中国科学院上海生命科学研究院 | Protein capable of adjusting sperm capacitation and use thereof |
CN101724612A (en) * | 2008-10-24 | 2010-06-09 | 李建远 | Human epididymis expression sperm binding protein HEL-128 as well as coding gene and application thereof |
CN101878747A (en) * | 2010-06-28 | 2010-11-10 | 中国人民解放军第四军医大学 | Constructing method of mouse model for RdRp controllable express and in vivo observation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4653915B2 (en) * | 2001-10-29 | 2011-03-16 | 独立行政法人科学技術振興機構 | Systemic lupus erythematosus model non-human animal |
US8203030B2 (en) * | 2007-09-05 | 2012-06-19 | The Regents Of The University Of California | Transgenic mouse models for diseases caused by mtDNA mutations and related methods |
-
2013
- 2013-10-16 CN CN201310485227.5A patent/CN103609526B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1646562A (en) * | 2002-01-30 | 2005-07-27 | 爱丁堡大学 | Pluripotency determining factors and uses thereof |
CN101396564A (en) * | 2007-09-24 | 2009-04-01 | 中国科学院上海生命科学研究院 | Protein capable of adjusting sperm capacitation and use thereof |
CN101724612A (en) * | 2008-10-24 | 2010-06-09 | 李建远 | Human epididymis expression sperm binding protein HEL-128 as well as coding gene and application thereof |
CN101878747A (en) * | 2010-06-28 | 2010-11-10 | 中国人民解放军第四军医大学 | Constructing method of mouse model for RdRp controllable express and in vivo observation |
Non-Patent Citations (3)
Title |
---|
"ET克隆的引用及Resp18基因敲除小鼠模型的初步建立";杨建岭;《中国优秀硕士学位论文全文数据库基础科学辑》;20080415(第04期);第43-60页 * |
"Mitochondria, spermatogenesis and male infertility";Singh Rajender等;《Mitochondrion》;20100601;第10卷;第419-428页 * |
"The Membrane-bound GTPase Guf1 Promotes Mitochondrial Protein Synthesis under Suboptimal Conditions";Heike Bauerschmitt等;《The Journal of Biological Chemistry》;20080428;第283卷(第25期);第17139-17146页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103609526A (en) | 2014-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hou et al. | NDUFAB1 confers cardio-protection by enhancing mitochondrial bioenergetics through coordination of respiratory complex and supercomplex assembly | |
Neesen et al. | Disruption of an inner arm dynein heavy chain gene results in asthenozoospermia and reduced ciliary beat frequency | |
Stefanini et al. | Trichothiodystrophy: from basic mechanisms to clinical implications | |
Luo et al. | Sperm mitochondria in reproduction: good or bad and where do they go? | |
KR100603683B1 (en) | Synovial Membrane Cell Protein | |
JP4573876B2 (en) | Methods for determining genotoxicity | |
Ye et al. | Molecular and expression characterization of a nanos1 homologue in Chinese sturgeon, Acipenser sinensis | |
Zhang et al. | Regulation of lipoprotein assembly, secretion and fatty acid β-oxidation by Krüppel-like transcription factor, klf-3 | |
McDermott et al. | Role of human Na, K‐ATPase alpha 4 in sperm function, derived from studies in transgenic mice | |
Nagao et al. | Higd1a improves respiratory function in the models of mitochondrial disorder | |
Ramesha et al. | Deep proteome profiling of semen of Indian indigenous Malnad Gidda (Bos indicus) cattle | |
Fujii et al. | A defect in purine nucleotide metabolism in the silkworm, Bombyx mori, causes a translucent larval integument and male infertility | |
Lin et al. | Molecular characterization, dynamic transcription, and potential function of KIF3A/KIF3B during spermiogenesis in Opsariichthys bidens | |
CA2527957A1 (en) | Use of genes differentially expressed during aging of liver for treatment and diagnosis | |
Cao et al. | Transcriptional inhibition of steroidogenic factor 1 in vivo in Oreochromis niloticus increased weight and suppressed gonad development | |
CN103609526B (en) | The application of mitochondrial protein translation factor Guf1 in male sterile research | |
Yang et al. | MNSFβ regulates placental development by conjugating IGF2BP2 to enhance trophoblast cell invasiveness | |
Zupkovitz et al. | Phylogenetic analysis and expression profiling of the Klotho gene family in the short-lived African killifish Nothobranchius furzeri | |
Liu et al. | AIF3 splicing switch triggers neurodegeneration | |
Sarver et al. | Hypermetabolism in mice carrying a near-complete human chromosome 21 | |
JP4324473B2 (en) | Sperm factor sequence | |
Bu et al. | Origin of a rapidly evolving homeostatic control system programming testis function | |
Morrison | Evidence of a Novel Sodium Hydrogen Exchanger With Sperm Specific Expression | |
Chen et al. | Impaired fertility in 4930590J08Rik mutant male mice is associated with defective sperm energy metabolism | |
Williams et al. | CDK-11-Cyclin L is required for gametogenesis and fertility in C. elegans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |